Search Results for "Asahi Kasei A Bpep"

03:45 EDT 25th October 2014 | BioPortfolio

Matching Channels

None

Matching News

Asahi Kasei Corporation: Company Profile and SWOT Analysis

Recently added to the BioPortfolio report store, Asahi Kasei Corporation: Company Profile and SWOT Analysis is a new report from ICD Research published on 2011-09-09. This 35-page report is availabl...

Asahi Kasei Zoll Medical obtains Japanese approval for R Series Monitor/Defibrillator

Asahi Kasei Zoll Medical (AZM), the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare for its R Series Monitor/Defibrillator.

Zoll Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market the R Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has recei...

Dutch RAV Gelderland-Midden Adopts ZOLL AutoPulse Non-Invasive Cardiac Support Pump

Achieves 75% ROSC Rate in Patients during the First 3 Weeks ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that ...

Boston Sci Links With Guidewire Specialist In Pursuit Of 2015 FFR Launch

Boston Scientific signed an agreement with the Japanese guidewire-maker Asahi Intecc to develop a fractional flow reserve wire that Boston seeks to launch as part of its first FFR system next year. As...

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (F...

Roughly 90% Of Large Japanese Companies Extend Care Leave: Asahi Survey

With the turnover of nursing and care employees being 100,000 per year in Japan, roughly 90% of large companies in the country are extending nursing leave to a period longer than that required by law,...

Auxilium receives US$10m milestone payment from Asah Kasei Pharma

After successful application to PMDA for Xiaflex

Matching PubMed Articles

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement